| ID | 117233 |
| 著者 |
板東, 浩
Kanaiso Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association
KAKEN研究者をさがす
Yamashita, Hisako
Kanaiso Hospital
Kato, Yoshinobu
Kanaiso Hospital
Ogura, Katsunori
Kanaiso Hospital
Kato, Yoshikane
Kanaiso Hospital
Kanazawa, Setsuko
Kanaiso Hospital
|
| キーワード | Type 2 diabetes
Obesity
Oral semaglutide
Weight
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | Background: Obesity and Type 2 Diabetes (T2D) are crucial problems worldwide. Oral semaglutide (Rybelsus) was introduced to medical practice for Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA). Case presentation: The patient is 24-year-old female with obesity (BMI 39.3 kg/m2), T2D and fatty liver. Results: She started and increased Rybelsus from 3mg, 7mg to 14mg/day each 4 weeks. She showed significant efficacy for 4 months as HbA1c 6.3% to 5.6% and weight 107kg to 103kg, without Gastrointestinal Adverse Events (GIAEs). Discussion: Rybelsus is provided just after waking up, and kept >30 min fasting period. Longer fasting time may contribute current effect.
|
| 掲載誌名 |
Journal of Obesity and Diabetes
|
| ISSN | 2638812X
|
| 出版者 | Edelweiss Publications
|
| 巻 | 5
|
| 号 | 1
|
| 開始ページ | 11
|
| 終了ページ | 14
|
| 発行日 | 2022-06-22
|
| 権利情報 | This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
|
